A PYMNTS Company

US: Centene to buy smaller rival WellCare for $15.27 billion

By  |  March 27, 2019

US health insurer Centene confirmed on Wednesday that it would buy WellCare Health Plans in a cash-and-stock deal to bulk up its government-backed health-care business, valuing its smaller rival at $15.27 billion.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Reuters had reported on Tuesday that the companies were in advanced talks over a deal.

    The acquisition would likely reduce Centene’s dependence on the Obamacare health-care exchanges at a time when the Trump administration has stepped up its assault on former President Barack Obama’s signature health-care law.

    Earlier this week, the Department of Justice (DOJ) backed a federal judge’s ruling that Obamacare violated the US Constitution because it required people to buy health insurance.

    Centene relies on its Obamacare business for about 40 percent of its earnings, making it vulnerable to the DOJ decision, according to SVB Leerink analyst Ana Gupte.

    Full Content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.